RYANN LAGOMARSINO: Open Payments
NPI 1366091639 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$515 in 24 payments from 12 companies in 2025. Trend: 2023 $630 · 2024 $515 · 2025 $515
Food & beverage: $515
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $87 |
| Astellas Pharma US Inc | 3 | $75 |
| Exact Sciences Corporation | 4 | $71 |
| Biogen, Inc. | 2 | $54 |
| Hologic Sales and Service, LLC | 2 | $44 |
| Exeltis, USA Inc. | 2 | $41 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $39 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Novo Nordisk Inc | 1 | $25 |
| Lundbeck LLC | 1 | $22 |
Products named: Veozah, Cologuard Collection Kit, ZURZUVAE, SLYND, UBRELVY, QULIPTA, MYFEMBREE, Wegovy.
Industry payments across ID — which companies pay providers there.
